United States Antiandrogen Monotherapy Market Research Report Forecast 2017-2022

July 2017 | 112 pages | ID: UF35991EC0EEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The United States Antiandrogen Monotherapy Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Antiandrogen Monotherapy industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Antiandrogen Monotherapy market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

Pfizer Inc. (USA)
Abbott Laboratories (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Immunomedics, Inc. (USA)
Indevus Pharmaceuticals Inc. (USA)
Novartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)

United States Antiandrogen Monotherapy Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

United States Antiandrogen Monotherapy Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 ANTIANDROGEN MONOTHERAPY MARKET OVERVIEW

1.1 Product Overview and Scope of Antiandrogen Monotherapy
1.2 Antiandrogen Monotherapy Market Segmentation by Type
  1.2.1 United States Production Market Share of Antiandrogen Monotherapy by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Antiandrogen Monotherapy Market Segmentation by Application
  1.3.1 Antiandrogen Monotherapy Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Antiandrogen Monotherapy (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON ANTIANDROGEN MONOTHERAPY INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES ANTIANDROGEN MONOTHERAPY MARKET COMPETITION BY MANUFACTURERS

3.1 United States Antiandrogen Monotherapy Production and Share by Manufacturers (2015 and 2016)
3.2 United States Antiandrogen Monotherapy Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Antiandrogen Monotherapy Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Antiandrogen Monotherapy Manufacturing Base Distribution, Production Area and Product Type
3.5 Antiandrogen Monotherapy Market Competitive Situation and Trends
  3.5.1 Antiandrogen Monotherapy Market Concentration Rate
  3.5.2 Antiandrogen Monotherapy Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES ANTIANDROGEN MONOTHERAPY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Antiandrogen Monotherapy Production and Market Share by Type (2012-2017)
4.2 United States Antiandrogen Monotherapy Revenue and Market Share by Type (2012-2017)
4.3 United States Antiandrogen Monotherapy Price by Type (2012-2017)
4.4 United States Antiandrogen Monotherapy Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES ANTIANDROGEN MONOTHERAPY MARKET ANALYSIS BY APPLICATION

5.1 United States Antiandrogen Monotherapy Consumption and Market Share by Application (2012-2017)
5.2 United States Antiandrogen Monotherapy Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES ANTIANDROGEN MONOTHERAPY MANUFACTURERS ANALYSIS

6.1 Pfizer Inc. (USA)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Abbott Laboratories (USA)
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Genentech Inc. (USA)
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 GlaxoSmithKline Plc (UK)
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Immunomedics, Inc. (USA)
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Indevus Pharmaceuticals Inc. (USA)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Novartis AG (Switzerland)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 OSI Pharmaceuticals, Inc. (USA)
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Paladin Labs Inc. (Canada)
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 ANTIANDROGEN MONOTHERAPY MANUFACTURING COST ANALYSIS

7.1 Antiandrogen Monotherapy Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antiandrogen Monotherapy

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antiandrogen Monotherapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2016
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES ANTIANDROGEN MONOTHERAPY MARKET FORECAST (2017-2022)

11.1 United States Antiandrogen Monotherapy Production, Revenue Forecast (2017-2022)
11.2 United States Antiandrogen Monotherapy Production, Consumption Forecast by Regions (2017-2022)
11.3 United States Antiandrogen Monotherapy Production Forecast by Type (2017-2022)
11.4 United States Antiandrogen Monotherapy Consumption Forecast by Application (2017-2022)
11.5 Antiandrogen Monotherapy Price Forecast (2017-2022)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antiandrogen Monotherapy
Table Classification of Antiandrogen Monotherapy
Figure United States Sales Market Share of Antiandrogen Monotherapy by Type in 2016
Table Application of Antiandrogen Monotherapy
Figure United States Sales Market Share of Antiandrogen Monotherapy by Application in 2016
Figure United States Antiandrogen Monotherapy Sales and Growth Rate (2011-2021)
Figure United States Antiandrogen Monotherapy Revenue and Growth Rate (2011-2021)
Table United States Antiandrogen Monotherapy Sales of Key Manufacturers (2015 and 2016)
Table United States Antiandrogen Monotherapy Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antiandrogen Monotherapy Sales Share by Manufacturers
Figure 2016 Antiandrogen Monotherapy Sales Share by Manufacturers
Table United States Antiandrogen Monotherapy Revenue by Manufacturers (2015 and 2016)
Table United States Antiandrogen Monotherapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Antiandrogen Monotherapy Revenue Share by Manufacturers
Table 2016 United States Antiandrogen Monotherapy Revenue Share by Manufacturers
Table United States Market Antiandrogen Monotherapy Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Antiandrogen Monotherapy Average Price of Key Manufacturers in 2015
Figure Antiandrogen Monotherapy Market Share of Top 3 Manufacturers
Figure Antiandrogen Monotherapy Market Share of Top 5 Manufacturers
Table United States Antiandrogen Monotherapy Sales by Type (2012-2017)
Table United States Antiandrogen Monotherapy Sales Share by Type (2012-2017)
Figure United States Antiandrogen Monotherapy Sales Market Share by Type in 2015
Table United States Antiandrogen Monotherapy Revenue and Market Share by Type (2012-2017)
Table United States Antiandrogen Monotherapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antiandrogen Monotherapy by Type (2012-2017)
Table United States Antiandrogen Monotherapy Price by Type (2012-2017)
Figure United States Antiandrogen Monotherapy Sales Growth Rate by Type (2012-2017)
Table United States Antiandrogen Monotherapy Sales by Application (2012-2017)
Table United States Antiandrogen Monotherapy Sales Market Share by Application (2012-2017)
Figure United States Antiandrogen Monotherapy Sales Market Share by Application in 2016
Table United States Antiandrogen Monotherapy Sales Growth Rate by Application (2012-2017)
Figure United States Antiandrogen Monotherapy Sales Growth Rate by Application (2012-2017)
Table Pfizer Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Abbott Laboratories (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbott Laboratories (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Genentech Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Genentech Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Genentech Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Market Share (2012-2017)
Table Immunomedics, Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Immunomedics, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Immunomedics, Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Novartis AG (Switzerland) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis AG (Switzerland) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG (Switzerland) Antiandrogen Monotherapy Market Share (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Market Share (2012-2017)
Table Paladin Labs Inc. (Canada) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antiandrogen Monotherapy
Figure Manufacturing Process Analysis of Antiandrogen Monotherapy
Figure Antiandrogen Monotherapy Industrial Chain Analysis
Table Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2016
Table Major Buyers of Antiandrogen Monotherapy
Table Distributors/Traders List
Figure United States Antiandrogen Monotherapy Production and Growth Rate Forecast (2017-2022)
Figure United States Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2017-2022)
Table United States Antiandrogen Monotherapy Production Forecast by Type (2017-2022)
Table United States Antiandrogen Monotherapy Consumption Forecast by Application (2017-2022)